DRUGS IN R&D
ISSN:1174-5886

DRUGS IN R&D

DRUGS R&D
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:8 Weeks
新锐分区:医学3区
年发文量:46
影响因子:2.1
JCR分区:Q3

基本信息

Drugs in R&D是一本国际性、同行评审、开放获取、仅在线的期刊,提供来自药物研发各个阶段的及时信息,为临床实践提供信息。医疗保健决策者因此提供了有关药物在治疗中的发展位置的知识。与临床药物开发直接相关的临床前研究;符合上述标准的简短通信和案例研究报告也将得到考虑;也可考虑进行审查。
1174-5886SCIE/Scopus收录/DOAJ开放期刊
2.1
2.5
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
222/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
194/353
39
46
1%08 WeeksGBP2390; USD3490; EUR2790Pharmacology, Toxicology and Pharmaceutics-Pharmacology
4.8%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
91.30%100%-
CiteScore:4.10
SJR:0.691
SNIP:0.899
学科类别分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q3
173 / 321

期刊高被引文献

Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0269-9
Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0266-z
A Clinician’s Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00288-x
Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon
来源期刊:Drugs in R&DDOI:10.1007/s40268-018-0259-3
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0272-1
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00286-z
Elderly Bleeding Risk of Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Cohort Studies
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0275-y
Ulcerative Colitis: Shifting Sands
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0263-2
S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0265-0
Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00285-0
Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0274-z
The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00290-3
Extrapolation of Drug Clearance in Children ≤\u20092 Years of Age from Empirical Models Using Data from Children (>\u20092 Years) and Adults
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00291-2
Apremilast Normalizes Gene Expression of Inflammatory Mediators in Human Keratinocytes and Reduces Antigen-Induced Atopic Dermatitis in Mice
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00284-1
Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00280-5
Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0262-3
Amount of Cycloserine Emanating from Terizidone Metabolism and Relationship with Hepatic Function in Patients with Drug-Resistant Tuberculosis
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00281-4
Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0273-0
A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney Transplantation
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0271-2
Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0261-4
Towards a Generic Tool for Prediction of Meropenem Systemic and Infection-Site Exposure: A Physiologically Based Pharmacokinetic Model for Adult Patients with Pneumonia
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0268-x
Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0277-9
Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Stroke Rehabilitation: A Prospective Observational Pilot Cohort Study
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00287-y
Prediction of Drug–Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00282-3
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0264-1
Assessment of Taste and Grittiness of Riomet® ER Strawberry, Riomet® ER Grape, Riomet® Cherry, and Metformin Immediate-Release Tablets in Healthy Subjects
来源期刊:Drugs in R&DDOI:10.1007/s40268-018-0260-x
Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study
来源期刊:Drugs in R&DDOI:10.1007/s40268-018-0258-4
Vasodepressor Effects of Adenosine in the Cat are Independent of Cyclooxygenase, Potassium Channels, and Nitric Oxide Pathways
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00283-2
Correction to: Safety and Efficacy of 0.5% Carbomer 980 Gel for Treatment of Symptoms of Common Cold: Results of 2 Randomized Trials
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0279-7
Acknowledgement to Referees
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-00289-w
Safety and Efficacy of 0.5% Carbomer 980 Gel for Treatment of Symptoms of Common Cold: Results of 2 Randomized Trials
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0270-3
Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0278-8
Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0267-y
Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets
来源期刊:Drugs in R&DDOI:10.1007/s40268-019-0276-x

相关文章

2026年3月发布
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区